v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT05225285 |
Full text link
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
val.valim@gmail.com |
Registration date
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
2022-02-04 |
Recruitment status
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
Recruiting |
Study design
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
Blind label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
Study aim
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
Prevention |
Inclusion criteria
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
inclusion criteria: age between 3 and 17 years old (vacc and bntc groups) age between 18 and 49 years old (adu group) |
Exclusion criteria
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
pregnant teenagers; history of severe allergic reaction (anaphylaxis, urticaria or angioedema) to any previously administered vaccine; have previously received a vaccine against covid-19; personal history of sars-cov-2-related multisystem inflammatory syndrome (mis-c); immunosuppressed due to conditions such as inborn error of metabolism, hiv infection, neoplasia or use of immunosuppressive drugs (systemic corticosteroids for more than 14 days or another immunosuppressant). |
Number of arms
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
3 |
Funding
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
Federal University of Espirito Santo |
Inclusion age min
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
3 |
Inclusion age max
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
49 |
Countries
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
Brazil |
Type of patients
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
Healthy volunteers |
Severity scale
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
N/A |
Total sample size
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
1120 |
primary outcome
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
Antigen-specific stimulation of peripheral blood mononuclear cells in vitro;B lymphocytes;Chemiluminescence serological assay for qualitative and quantitative determination of neutralizing antibodies against Spike protein (anti-SARS-Cov-2 anti-IgG-S);Dosage of systemic soluble factors;intracytoplasmic cytokines;Serological assay by chemiluminescence for qualitative and quantitative determination of specific IgG antibodies against the nucleocapsid protein of SARS-Cov-2;T lymphocytes;Viral neutralization assay |
Notes
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
Phase 3 |
Arms
Last imported at : Feb. 6, 2022, 2 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "2;4 weeks apart (3-17 years old)", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "2;4 weeks apart (3-17 years old)", "treatment_id": 327, "treatment_name": "Coronavac", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "2;4 weeks apart (18-49 years old)", "treatment_id": 327, "treatment_name": "Coronavac", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}] |